This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cellectis S.a.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Innovator Spotlight: Violette Thermes and Her Groundbreaking Patent in Molecular Biology
Introduction: Violette Thermes, an accomplished inventor based in Paris, France, has made significant contributions to the field of molecular biology. With a focus on innovative genetic methodologies, she holds a patent that showcases her expertise and creativity. Her work aims to address critical challenges in the integration of polynucleotides, which can have wide-reaching applications in various fields, including medicine and agriculture.
Latest Patents: Violette Thermes is the inventor of a patent titled "Random Integration of a Polynucleotide by In Vivo Linearization." This innovative method facilitates the in vivo generation of a linear polynucleotide with 5' and 3' free ends, derived from a vector that lacks free ends. The patent outlines a process in which the resulting linear polynucleotide can be integrated into the genome of a host cell. This method has significant implications, as it can lead to the production of proteins, biomolecules, and even vaccines. Moreover, it holds promise for creating transgenic plants and animals, as well as providing treatment options for various health conditions.
Career Highlights: Violette Thermes works at Cellectis S.A., a prominent company known for its pioneering advancements in gene-editing technologies. Her involvement at Cellectis has allowed her to collaborate with some of the leading experts in the field, significantly enhancing her research and innovative capabilities.
Collaborations: During her career, Violette has had the privilege of working alongside notable colleagues, including Andre Choulika and Jean-Stephane Joly. These collaborations have helped foster a dynamic exchange of ideas and have contributed to the advancement of projects that aim to harness the potential of genetic engineering for beneficial applications.
Conclusion: Violette Thermes exemplifies the spirit of innovation and dedication that drives the field of molecular biology forward. Her patent on the random integration of polynucleotides not only highlights her inventive capabilities but also opens new avenues for research and therapeutic applications. As she continues her work at Cellectis S.A., her contributions are sure to influence the landscape of genetic research and its practical uses in the years to come.